drugset / Trial / NCT04715932
Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main aim of this study is to determine the effects of short-term treatment with hesperidin on COVID-19 symptoms in comparison with a placebo. Treatment effects will be observed through a symptoms diary that will be completed by participants throughout the study and by taking the oral temperature daily.
Timeline
- Start
- 2021-02-18
- Primary completion
- 2021-05-25
- Completion
- 2021-06-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hesperidin | Small molecule | 1000 mg | Oral |